Table 5. Patients with malignant pathology following RRBSO.
| Patient | Genetic test result | Age at testing | Cancer history | Surgery performed | Final pathology |
|---|---|---|---|---|---|
| Patient 84 | Negative | 41 | Cervical cancer | TAH BSO | Ovarian malignancy |
| Patient 112 | Negative | 42 | HR+ breast cancer | BSO | Ovarian/tubal malignancy |
| Patient 218 | Negative | 49 | HR+ breast cancer | TAH BSO | Uterine malignancy |
| Patient 343 | Favor polymorphism | 67 | HR+ breast cancer | TAH BSO | Uterine malignancy |
RRBSO, risk-reducing bilateral salpingo-oophorectomy; TAH, total abdominal hysterectomy; BSO, bilateral salpingo-oophorectomy; HR, hormone receptor.